{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:32:07Z","timestamp":1781724727178,"version":"3.54.5"},"reference-count":34,"publisher":"Begell House","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Eukaryot Gene Expr"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Diabetic peripheral neuropathy (DPN) is a diabetic complication, featured by impaired vascular functions. This study investigates the roles of arachidonate 15-lipoxygenase (ALOX15) in DPN. High glucose (HG) is used to establish &lt;i&gt;in vitro&lt;\/i&gt; DPN model. mRNA levels are detected using reverse transcription quantitative polymerase chain reaction (RT-qPCR). Protein expression is detected using Western blot. The release of MDA, GSH, and iron is detected using ELISA assays. Mitochondrial functions are detected using immunofluorescence. Cell viability is detected using CCK-8 assay. Cell proliferation is detected using colony formation. Vascular angiogenesis is detected using tube formation assay. The death of human umbilical vein endothelial cells (HUVECs) is detected using TUNEL staining. The results show that HG treatment increases the release of ox-mtDNA. Ox-mtDNA stress promotes the lipid peroxidation and the accumulation of iron in an ALOX15-depedent manner, resulting in the ferroptosis of HUVECs. Moreover, HG treatment suppresses the expression of proliferation and angiogenesis of HUVECs. However, ALOX15 deficiency promotes the proliferation and angiogenesis of HUVECs, as well as suppresses the ox-mtDNA synthesis and ferroptosis. In conclusion, inhibition of ALOX15 suppresses ox-mtDNA synthesis and the ferroptosis of endothelial cells in DPN. Therefore, targeting ALOX15 may be a promising strategy for DPN.\n<\/p>","DOI":"10.1615\/critreveukaryotgeneexpr.2025059114","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T15:21:42Z","timestamp":1748877702000},"page":"27-36","source":"Crossref","is-referenced-by-count":2,"title":["Mitochondrial DNA Stress Promotes the Ferroptosis of Endothelial Cells in Diabetic Peripheral Neuropathy by Upregulating ALOX15"],"prefix":"10.1615","volume":"35","author":[{"given":"Xuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqun","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, Tesfaye S. Diabetic peripheral neuropathy: Advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019;7:938\u00e2\u0080\u009348.","DOI":"10.1016\/S2213-8587(19)30081-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Elafros MA, Andersen H, Bennett DL, Savelieff MG, Viswanathan V, Callaghan BC, Feldman EL. Towards prevention of diabetic peripheral neuropathy: Clinical presentation, pathogenesis, and new treatments. Lancet Neurol. 2022;21:922\u00e2\u0080\u009336.","DOI":"10.1016\/S1474-4422(22)00188-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Wang W, Ji Q, Ran X, Li C, Kuang H, Yu X, Fang H, Yang J, Liu J, Xue Y, Feng B, Lei M, Zhu D. Prevalence and risk factors of diabetic peripheral neuropathy: A population-based cross-sectional study in China. Diabetes Metab Res Rev. 2023;39:e3702.","DOI":"10.1002\/dmrr.3702"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Jang HN, Oh TJ. Pharmacological and nonpharmacological treatments for painful diabetic peripheral neuropathy. Diabetes Metab J. 2023;47:743-56.","DOI":"10.4093\/dmj.2023.0018"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Jin Q, Liu T, Ma F, Fu T, Yang L, Mao H, Wang Y, Peng L, Li P, Zhan Y. Roles of Sirt1 and its modulators in diabetic microangiopathy: A review. Int J Biol Macromol. 2024;264:130761.","DOI":"10.1016\/j.ijbiomac.2024.130761"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Rhein S, Costalunga R, Inderhees J, G\u00fcrtzgen T, Faupel TC, Shaheryar Z, Arrulo Pereira A, Othman A, Begemann K, Binder S, St\u00f6lting I, Dorta V, Nawroth PP, Fleming T, Oexle K, Prevot V, Nogueiras R, Meyh\u00f6fer S, Meyh\u00f6fer SM, Schwaninger M. The reactive pyruvate metabolite dimethylglyoxal mediates neurological consequences of diabetes. Nat Commun. 2024;15:5745.","DOI":"10.1038\/s41467-024-50089-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Donoso MV, Mascayano MJ, Poblete IM, Huidobro-Toro JP. Increased ATP and ADO overflow from sympathetic nerve endings and mesentery endothelial cells plus reduced nitric oxide are involved in diabetic neurovascular dysfunction. Front Pharmacol. 2018;9:546.","DOI":"10.3389\/fphar.2018.00546"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 2022;82:2215-27.","DOI":"10.1016\/j.molcel.2022.03.022"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Cai W, Liu L, Shi X, Liu Y, Wang J, Fang X, Chen Z, Ai D, Zhu Y, Zhang X. Alox15\/15-HpETE aggravates myocardial ischemia-reperfusion injury by promoting cardiomyocyte ferroptosis. Circulation. 2023;147:1444-60.","DOI":"10.1161\/CIRCULATIONAHA.122.060257"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Suzuki H, Kayama Y, Sakamoto M, Iuchi H, Shimizu I, Yoshino T, Katoh D, Nagoshi T, Tojo K, Minamino T, Yoshimura M, Utsunomiya K. Arachidonate 12\/15-lipoxygenase-induced inflammation and oxidative stress are involved in the development of diabetic cardiomyopathy. Diabetes. 2015;64:618-30.","DOI":"10.2337\/db13-1896"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Yuan H, Reddy MA, Deshpande S, Jia Y, Park JT, Lanting LL, Jin W, Kato M, Xu ZG, Das S, Natarajan R. Epigenetic histone modifications involved in profibrotic gene regulation by 12\/15-lipoxygenase and its oxidized lipid products in diabetic nephropathy. Antioxid Redox Signal. 2016;24:361-75.","DOI":"10.1089\/ars.2015.6372"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Newman LE, Shadel GS. Mitochondrial DNA release in innate immune signaling. Annu Rev Biochem. 2023;92: 299-332.","DOI":"10.1146\/annurev-biochem-032620-104401"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Hu MM, Shu HB. Mitochondrial DNA-triggered innate immune response: Mechanisms and diseases. Cell Mol Immunol. 2023;20:1403-12.","DOI":"10.1038\/s41423-023-01086-x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Malaviya P, Kumar J, Kowluru RA. Role of ferroptosis in mitochondrial damage in diabetic retinopathy. Free Radic Biol Med. 2024;225:821-32.","DOI":"10.1016\/j.freeradbiomed.2024.10.296"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Li Y, Cai Z, Ma W, Bai L, Luo E, Lin Y. A DNA tetrahedron- based ferroptosis-suppressing nanoparticle: Superior delivery of curcumin and alleviation of diabetic osteoporosis. Bone Res. 2024;12:14.","DOI":"10.1038\/s41413-024-00319-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Jin J, Wang Y, Zheng D, Liang M, He Q. A novel identified circular RNA, mmu_mmu_circRNA_0000309, involves in germacrone-mediated improvement of diabetic nephropathy through regulating ferroptosis by targeting miR-188-3p\/GPX4 signaling axis. Antioxid Redox Signal. 2022;36:740-59.","DOI":"10.1089\/ars.2021.0063"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Monzel AS, Enriquez JA, Picard M. Multifaceted mitochondria: Moving mitochondrial science beyond function and dysfunction. Nat Metab. 2023;5:546-62.","DOI":"10.1038\/s42255-023-00783-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Dong L, Zhou Y, Wang L, Mao X, Wang J, Du Z, Che X, Li Y. Neobavaisoflavone protects H9c2 cells against H(2)O(2)-induced mitochondrial dysfunction through ALOX15\/PGC1-alpha axis. J Biochem Mol Toxicol. 2024;38:e70043.","DOI":"10.1002\/jbt.70043"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Tong J, Lan XT, Zhang Z, Liu Y, Sun DY, Wang XJ, Ou-Yang SX, Zhuang CL, Shen FM, Wang P, Li DJ. Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: Potential involvement of PANoptosis. Acta Pharmacol Sin. 2023;44:1014-28.","DOI":"10.1038\/s41401-022-01010-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Xian H, Watari K, Sanchez-Lopez E, Offenberger J, Onyuru J, Sampath H, Ying W, Hoffman HM, Shadel GS, Karin M. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022;55:1370-85.e1378.","DOI":"10.1016\/j.immuni.2022.06.007"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Wang D, Liang W, Huo D, Wang H, Wang Y, Cong C, Zhang C, Yan S, Gao M, Su X, Tan X, Zhang W, Han L, Zhang D, Feng H. SPY1 inhibits neuronal ferroptosis in amyotrophic lateral sclerosis by reducing lipid peroxidation through regulation of GCH1 and TFR1. Cell Death Differ. 2023;30:369-82.","DOI":"10.1038\/s41418-022-01089-7"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Wang H, Yu X, Liu D, Qiao Y, Huo J, Pan S, Zhou L, Wang R, Feng Q, Liu Z. VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating Nrf2\/HO-1 signaling pathway in diabetic nephropathy. Adv Sci. 2024;11:e2305563.","DOI":"10.1002\/advs.202305563"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Hu M, Jiang W, Ye C, Hu T, Yu Q, Meng M, Sun L, Liang J, Chen Y. Honokiol attenuates high glucose-induced peripheral neuropathy via inhibiting ferroptosis and activating AMPK\/SIRT1\/PGC-1alpha pathway in Schwann cells. Phytother Res. 2023;37:5787-802.","DOI":"10.1002\/ptr.7984"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266-82.","DOI":"10.1038\/s41580-020-00324-8"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: Molecular mechanisms and health implications. Cell Res. 2021;31:107-25.","DOI":"10.1038\/s41422-020-00441-1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Zhao QX, Yan SB, Wang F, Li XX, Shang GK, Zheng ZJ, Xiao J, Lin ZW, Li CB, Ji XP. STING deficiency alleviates ferroptosis through FPN1 stabilization in diabetic kidney disease. Biochem Pharmacol. 2024;222:116102.","DOI":"10.1016\/j.bcp.2024.116102"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Petrica L, Gadalean F, Muntean DM, Jianu DC, Vlad D, Dumitrascu V, Bob F, Milas O, Suteanu-Simulescu A, Glavan M, Ursoniu S, Balint L, Mogos-Stefan M, Ienciu S. C mitochondrial DNA and inflammation are associated with cerebral vessel remodeling and early diabetic kidney disease in patients with type 2 diabetes mellitus. Biomolecules. 2024;14(4):499.","DOI":"10.3390\/biom14040499"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Yan W, Cui X, Guo T, Liu N, Wang Z, Sun Y, Shang Y, Liu J, Zhu Y, Zhang Y, Chen L. ALOX15 aggravates metabolic dysfunction-associated steatotic liver disease in mice with type 2 diabetes via activating the PPARgamma\/CD36 axis. Antioxid Redox Signal. In press 2025.","DOI":"10.1089\/ars.2024.0670"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Elmasry K, Ibrahim AS, Saleh H, Elsherbiny N, Elshafey S, Hussein KA, Al-Shabrawey M. Role of endoplasmic reticulum stress in 12\/15-lipoxygenase-induced retinal microvascular dysfunction in a mouse model of diabetic retinopathy. Diabetologia. 2018;61:1220-32.","DOI":"10.1007\/s00125-018-4560-z"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Peng Y, Wen D, Lin F, Mahato RI. Co-delivery of siAlox15 and sunitinib for reversing the new-onset of type 1 diabetes in non-obese diabetic mice. J Control Release. 2018;292:1-12.","DOI":"10.1016\/j.jconrel.2018.10.032"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Klemmensen MM, Borrowman SH, Pearce C, Pyles B, Chandra B. Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics. 2024;21:e00292.","DOI":"10.1016\/j.neurot.2023.10.002"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Yao Y, Lei X, Wang Y, Zhang G, Huang H, Zhao Y, Shi S, Gao Y, Cai X, Gao S, Lin Y. A mitochondrial nanoguard modulates redox homeostasis and bioenergy metabolism in diabetic peripheral neuropathy. ACS Nano. 2023;17:22334-54.","DOI":"10.1021\/acsnano.3c04462"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Lawrence G, Holley CL, Schroder K. Come on mtDNA, light my fire. Immunity. 2022;55:1331-3.","DOI":"10.1016\/j.immuni.2022.07.011"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Xian H, Karin M. Oxidized mitochondrial DNA: A protective signal gone awry. Trends Immunol. 2023;44:188-200.","DOI":"10.1016\/j.it.2023.01.006"}],"container-title":["Critical Reviews in Eukaryotic Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/407ecf586dfef9e7\/CRE-59114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T06:18:52Z","timestamp":1758089932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/6dbf508d3b17c437,1795a7ae0f352901,407ecf586dfef9e7.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critreveukaryotgeneexpr.2025059114","relation":{},"ISSN":["1045-4403"],"issn-type":[{"value":"1045-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}